NSE BSE
parmax pharma limited stock

Parmax Pharma Limited Share Price

- - (%)
Sector: -

540359

PARMAX

img img img img
No Data Available

Parmax Pharma Limited Share Price Update


As of the latest trading session, Parmax Pharma Limited share price is currently at 32.45, which is up by 1.05 from its previous closing. Today, the stock has fluctuated between 29.83 and 32.90. Over the past year, Parmax Pharma Limited has achieved a return of 2.08 %. In the last month alone, the return has been -0.31 %.

Parmax Pharma Limited Performance

Day Range

Low29.83 High32.90
30.10

52 Week Range

Low 24.18 High 37.90
30.10

Open Price

29.91

Prev. Close

31.40

Volume (Shares)

1670.00

Total traded value

.50

Upper Circuit

38.10

Lower Circuit

25.40

Note: The current prices & values are delayed, Login to your account for live updates.

Parmax Pharma Limited Fundamentals


(Standalone)

Market Cap (Cr) 11.90
PE Ratio (TTM) 0.00
Book Value / Share 6.61
Beta 0.02
ROE -1.69%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.75

Parmax Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 1.33
Operating Expense 3.09
Net Profit -1.75
Net Profit Margin (%) -131.57
Earnings Per Share (EPS) -4.68
EBITDA -1.14
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.07
Operating Expense 5.43
Net Profit -1.37
Net Profit Margin (%) -33.66
Earnings Per Share (EPS) -3.66
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 1.40
Operating Expense 2.59
Net Profit -1.18
Net Profit Margin (%) -84.28
Earnings Per Share (EPS) -3.15
EBITDA -0.64
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 6.38
Operating Expense 6.06
Net Profit 0.17
Net Profit Margin (%) 2.66
Earnings Per Share (EPS) 0.46
EBITDA 0.84
Effective Tax Rate (%) 46.87
Particulars DEC 2022 (Values in Cr)
Revenue 5.35
Operating Expense 3.61
Net Profit 1.74
Net Profit Margin (%) 32.52
Earnings Per Share (EPS) 4.66
EBITDA 2.33
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 18.25
Operating Expense 18.01
Net Profit 0.14
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) -0.28
EBITDA 2.62
Effective Tax Rate (%) 53.33
Particulars MAR 2022 (Values in Cr)
Revenue 18.25
Operating Expense 18.01
Net Profit 0.14
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.38
EBITDA 2.62
Effective Tax Rate (%) 53.33
Particulars MAR 2021 (Values in Cr)
Revenue 26.20
Operating Expense 25.08
Net Profit 0.75
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 2.02
EBITDA 3.50
Effective Tax Rate (%) 37.19
Particulars MAR 2020 (Values in Cr)
Revenue 20.93
Operating Expense 20.30
Net Profit 0.43
Net Profit Margin (%) 2.05
Earnings Per Share (EPS) 1.15
EBITDA 1.87
Effective Tax Rate (%) 41.09
Particulars MAR 2019 (Values in Cr)
Revenue 12.01
Operating Expense 11.95
Net Profit 0.08
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.21
EBITDA 1.16
Effective Tax Rate (%) 20.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.16
ROE % -1.69
ROCE % 4.03
Total Debt to Total Equity 0.89
EBITDA Margin 15.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.39
ROE % 2.38
ROCE % 6.04
Total Debt to Total Equity 0.94
EBITDA Margin 14.41
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.07
ROE % 13.79
ROCE % 14.26
Total Debt to Total Equity 1.02
EBITDA Margin 13.44
Particulars MAR 2020 (Values in Cr)
Book Value / Share 11.38
ROE % 8.88
ROCE % 8.40
Total Debt to Total Equity 1.11
EBITDA Margin 8.93
Particulars MAR 2019 (Values in Cr)
Book Value / Share 10.41
ROE % 1.74
ROCE % 1.56
Total Debt to Total Equity 0.82
EBITDA Margin 9.66
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 17.61
Total Liabilities 17.61
Total Equity 5.85
Share Outstanding 4451150
Price to Book Ratio 2.31
Return on Assets (%) -0.59
Return on Capital (%) -1.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.05
Total Assets 17.97
Total Liabilities 17.97
Total Equity 5.95
Share Outstanding 4451150
Price to Book Ratio 3.05
Return on Assets (%) 0.78
Return on Capital (%) 1.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.54
Total Assets 22.72
Total Liabilities 22.72
Total Equity 5.81
Share Outstanding 4451150
Price to Book Ratio 2.72
Return on Assets (%) 3.31
Return on Capital (%) 6.7
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.76
Total Assets 21.06
Total Liabilities 21.06
Total Equity 5.06
Share Outstanding 4451150
Price to Book Ratio 0.00
Return on Assets (%) 2.03
Return on Capital (%) 4.25
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.56
Total Assets 19.70
Total Liabilities 19.70
Total Equity 4.63
Share Outstanding 4451150
Price to Book Ratio 0.00
Return on Assets (%) 0.39
Return on Capital (%) 0.8
Particulars MAR 2023 (Values in Cr)
Net Income 0.04
Cash from Operations 0.33
Cash from Investing -0.93
Cash from Financing -0.04
Net change in Cash -0.64
Free Cash Flow 1.26
Particulars MAR 2022 (Values in Cr)
Net Income 0.30
Cash from Operations 0.74
Cash from Investing -1.53
Cash from Financing -0.91
Net change in Cash -1.69
Free Cash Flow 2.28
Particulars MAR 2021 (Values in Cr)
Net Income 1.20
Cash from Operations 3.52
Cash from Investing -3.14
Cash from Financing 0.39
Net change in Cash 0.77
Free Cash Flow 6.67
Particulars MAR 2020 (Values in Cr)
Net Income 0.73
Cash from Operations 2.82
Cash from Investing -2.39
Cash from Financing -0.22
Net change in Cash 0.20
Free Cash Flow 5.22
Particulars MAR 2019 (Values in Cr)
Net Income 0.09
Cash from Operations 0.92
Cash from Investing -3.41
Cash from Financing 3.09
Net change in Cash 0.60
Free Cash Flow 4.33
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
Parmax Pharma Limited 31.40 0.00 4.74 11.75 24.18 / 37.90
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 30.90
  • 26 Days 30.80
  • 10 Days 31.00
  • 50 Days 30.70
  • 12 Days 30.90
  • 100 Days 30.90
  • 20 Days 31.00
  • 200 Days 29.70
30.67
PIVOT
First Resistance 32.73
Second Resistance 34.07
Third Resistance 36.13
First Support 29.33
Second Support 27.27
Third Support 25.93
RSI 53.94
MACD 0.17
Commodity Channel Index (CCI) 0.29
ADX 34.92
Williams % R -68.42

Over 1 Month

down

-0.31

Over 3 Months

down

-1.81

Over 6 Months

down

-0.31

Over 1 Year

down

2.08

Over 3 Years

down

-17.14

Over 5 Years

down

11.58

Parmax Pharma Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Parmax Pharma Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
69.16
Promoter Holdings
30.83
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Alkesh Mahasukh Gopani Shareholding of Promoter and Promoter Group 671380.0 17.95
Vipul Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 481370.0 12.87
Gosalia Meena Alkesh Public Shareholding 424800.0 11.35
Pradeep Ramniklal Gosalia Public Shareholding 253113.0 6.77
Shah Jyotsnaben Ramniklal Public Shareholding 250000.0 6.68
Umang Alkesh Gosalia Public Shareholding 100000.0 2.67
Gosalia Nimit P Public Shareholding 40000.0 1.07
Gosalia Vandana P Public Shareholding 40000.0 1.07
Pravina Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 700.0 0.02

Parmax Pharma Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Parmax Pharma Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Parmax Pharma Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Parmax Pharma Ltd?

Answer Field

The share price of Parmax Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 32.45.

What is the Market Cap of Parmax Pharma Ltd?

Answer Field

The market cap of Parmax Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 11.90 Cr. as of now.

What is the 52 Week High and Low of Parmax Pharma Ltd?

Answer Field

The 52 Week High and Low of Parmax Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 37.90 and ₹ 24.18.

How to Buy Parmax Pharma Ltd share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Parmax Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 2.08%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader